Viatris Inc
corporate_fare Company Profile
Viatris Inc (NASDAQ:VTRS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 28 items for VTRS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-17, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for VTRS spans SC TO-T/A, 10-Q, 8-K, SC TO-T.
Recent high-impact activity:
- Viatris Closes $36.50/Share Pacira Buy as Tender Hits 66.46%
- Pacira Faces Two Merger Suits and 15 Demand Letters Over 14D-9 Disclosures
- Viatris Q3: Flat $3.75B Revenue, $325M Net Loss on $453M Tax Hit; Nashik Plant Suspended
- Viatris Q3 Revenue $3.75B, Net Loss $325M; Raises 2026 Guidance Midpoints
- Viatris Posts $3.75B in Third-Quarter Revenue
Financial Snapshot
Short Interest & Short Volume
4.04 days to coverFINRA reported short interest of 35,240,834 shares in VTRS as of the October 30, 2026 settlement, a 7.1% decrease from the prior period — about 4.0 days to cover at its recent average daily volume. On November 20, 2026, 46.4% of VTRS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.